Recent publications on Cancer
McEvoy JP. What's hot: prostatic specific antigen: a useful screening test? GHC Medical Forum. 1991;1(5):17-8. PubMed
Davis RL. Blindness and the incidence of breast cancer. Epidemiology. 2(6):458, November 1991. PubMed
Montano D, Taplin S. A test of an expanded theory of reasoned action to predict mammography participation. Soc Sci Med., 1991;32(6):733-741. PubMed
Henderson MM. A population-based cancer prevention research unit. Cancer Detect Prev. 1991;15(1):17-9. PubMed
Katz SJ, Thomas DB, Hislop TG, Larson EB. Detection and time to diagnosis and treatment of breast cancer in Washington and British Columbia. Clin Res. 1991;39:143A. PubMed
Taplin SH, Anderman C, Grothaus L. Breast cancer risk and participation in mammographic screening. Abstract requested by the Clinical Digest Series. Obstetrics and Gynecology Digest. 1990;6:21-2. PubMed
Mustin H, Carter A, Sailer J, Thompson L. Screening for prostate cancer: is ultrasound the answer? HMO Pract. 1990;4(5):157-61. PubMed
Taplin SH, Thompson RS, Schnitzer F, Anderman C, Immanuel V. Revisions in the risk-based breast cancer screening program at Group Health Cooperative. Cancer. 1990;66(4):812-8. PubMed
The NCI Breast Cancer Screening Consortium. Screening mammography: a missed clinical opportunity? results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey studies. JAMA. 1990;264(1):54-8. PubMed
Schumacher MC, Jick SS, Jick H, Feld AD. Cimetidine use and gastric cancer. Epidemiology. 1990;1(3):251-4. PubMed
Henderson MM, Kushi LH, Thompson DJ, Gorbach SL, Clifford CK, Insull W Jr, Moskowitz M, Thompson RS. Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study. Prev Med. 1990;19(2):115-33. PubMed
Mahloch J, Paskett E, Henderson M, Grizzle J, Ross-Price M, Thompson RS. An evaluation of BSE frequency and quality and their relationship to breast lump detection. Prog Clin Biol Res. 1990;339:269-80. PubMed
Tompkins C, Gibaldi M, Stergachis A. Second cancers after treatment with antineoplastic agents. Newsl Int Society Pharmacoepidemiol. 1990. PubMed
Tulsky DS, Cella DF, Bonomi A, Lee-Riordan D, Silberman M, Purl S. The Functional Assessment of Cancer Therapy (FACT) scales: incorporating disease-specificity and subjectivity into quality of life (QL) assessment. Proceedings of the American Society of Clinical Oncology. 1990;9:307, #1190. PubMed
Mandelson MT, Daling JR, White E, Chu J, McKnight B. Further evidence that duration and recency of oral-contraceptive use are associated with invasive cervical cancer. Am J Epidemiol. 1990; 132, 77B. PubMed
Katz SJ, Larson EB, LoGerfo JP. The diffusion of mammography in Washington State and British Columbia: Effects on surveillance of breast cancer. Clin Res. 1990;38:715A. PubMed
Shy K, Chu J, Mandelson M, Greer B, Figge D. Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol. 1989;74(6):838-43. PubMed
Taplin S, Anderman C, Grothaus L. Breast cancer risk and participation in mammographic screening. Am J Public Health. 1989;79(11):1494-8. PubMed
Taplin SH. Breast cancer screening. A curious problem in primary care. J Fam Pract. 1989;29(3):247-8. PubMed
Beckmann AM, Daling JR, Sherman KJ, Maden C, Miller BA, Coates RJ, Kiviat NB, Myerson D, Weiss NS, Hislop TG, Beagrie M, McDougall JK. Human papillomavirus infection and anal cancer. Int J Cancer. 1989;43(6):1042-9. PubMed


